Skip to content
Sign up

Updated · published

Greater trochanteric pain syndrome (GTPS)

Greater trochanteric pain syndrome: gluteal tendinopathy rather than bursitis, the clinical tests, managing compression, and the exercises that work.

The essentials, in 30 seconds

Lateral hip pain in a woman aged 40 to 60 is above all a compression tendinopathy of the gluteal muscles, more than a bursitis: education and exercise first.

36%of patients keep symptoms at 5 years without active treatment

What it is
Above all a compression tendinopathy of the gluteus medius and minimus, with bursitis rarely isolated.
What points to it
Palpable trochanteric pain, aggravated when lying on the affected side at night, in a woman aged 40 to 60.
How it is decided
The diagnosis is clinical: pain reproduced on palpation, in prolonged single-leg stance and on uphill walking.
What to do first
Education and progressive exercise of the abductors: 78.5 % success at 52 weeks, against 57.1 % for corticosteroid injection.
Who is affected
Four women for every man, with a peak between 40 and 60 years.

What follows covers each of these points in detail, with sources. It is there if you need it.

This topic is taught in a course: Gluteus medius tendinopathy – Lateral hip pain, online with Anthony Baillon.

Chapter by chapter

1 / 8

7 article chapters · 45 min in total

Chapter 1

Understand◔ 7 min

GTPS is above all a compression tendinopathy of the gluteal muscles, not an isolated bursitis.

Profile
It is a predominantly female, late-onset condition: 4 women for 1 man, with a peak between 40 and 60 years.
Risk factors
The key risk factors include high BMI, low back pain, hip osteoarthritis and abductor weakness.
Mechanism
The mechanism is compression of the tendons by the iliotibial band, aggravated by adduction.
Course
Without active treatment, 36 % of patients keep persistent symptoms at 5 years.
Chapter 2

Diagnose◔ 7 min

The diagnosis of GTPS is a clinical cluster: palpation of the gluteal tendon then resisted abduction, Single Leg Stance, FADER.

Limited imaging
Imaging is of no use as a first-line investigation, except for red flags or if treatment fails.
Over-interpretation
The major risk of imaging is the over-interpretation of asymptomatic abnormalities.
Differential
The non-negotiable differential includes L5 radiculopathy, hip osteoarthritis, FAI and meralgia.
Classification
Stage-based classification doses rehabilitation: isometric in the acute phase, HSR in the chronic phase.
Chapter 3

Treat◔ 9 min

First-line management combines education and progressive abductor exercise, on moderate-strength evidence.

LEAP 2018
The LEAP trial shows 78.5 % success, against 57.1 % for corticosteroids at one year.
Positions to avoid
Education covers the compressive positions to avoid: crossed legs, standing on one hip, side-lying without a pillow.
Psychosocial
Kinesiophobia and catastrophising, from the initial assessment, predict treatment failure.
Central role of exercise
Exercise is the core of treatment, cautiously recommended by the Bremer 2025 review.
Chapter 4

Prevent◔ 5 min

Lasting recovery requires an active, patient-centred approach.

Education
Education is the key: avoid compression positions such as crossed legs.
Exercise
Exercise, that is progressive strengthening of the abductors, is the real treatment.
Graded return
The graded return is paced by tolerance: the 10 % per week rule is only a guide, with no validated threshold.
Self-management
Self-management is the ultimate goal: the patient becomes an expert in their condition.
Chapter 5

Women at risk◔ 5 min

GTPS has a marked sex bias, explained by pelvic anatomy: wide pelvis, Q angle, femoral anteversion.

Three subgroups
Three profiles are distinguished: sedentary postmenopausal, active masters and complicated chronic.
Comorbidities
Other associated tendinopathies should be screened for: rotator cuff, epicondyle, plantar.
Modifiable factors
BMI and a sedentary lifestyle are the major modifiable risk factors to address.
Wide pelvis
The wider female pelvis increases the lever arm in relative adduction.
Chapter 6

Clinical cases◔ 6 min

Familiar trochanteric palpation remains the pivot of the diagnosis, despite the pitfalls.

LEAP case
The typical case responds to an education and exercise protocol over 8 to 12 weeks.
Pitfalls
Classic pitfalls include meralgia paraesthetica, L5 radiculopathy and FAI.
Escalation
If this fails, shockwave therapy, PRP or surgery are discussed with the doctor, on conflicting evidence.
Meralgia case
A case of false meralgia resolved when the gluteal tendinopathy was treated rather than the nerve.
Chapter 7

In practice◔ 6 min

Interprofessional collaboration is essential for complex GTPS cases.

PROMs
Outcomes are measured with the provisional ICON measurement set, supplemented where needed by the VISA-G.
EBP barriers
The barriers to EBP (time, skills, resources) are real but surmountable.
VISA-G
The VISA-G has 8 items; ICON judges its clinimetrics insufficient but retains it for trials.
Red flags
Red flags include a history of cancer, fever or a progressive neurological deficit.
8

Train on this

Online

Lower limb

Gluteus medius tendinopathy – Lateral hip pain

Anthony Baillon

Next comes practice: the course that teaches this topic, with Anthony Baillon.

Our courses on this topic may be covered by DPC or FIFPL, the French continuing-education funding schemes, depending on your profession and situation.

Posted by

Anthony BAILLON

Physiotherapist


Qu'est-ce que le grand trochanter ?

Le grand trochanter est la saillie osseuse de la partie haute et externe du fémur, l'os de la cuisse. On le sent sous la peau, sur le côté de la hanche, en s'allongeant sur le flanc. Plusieurs muscles s'y attachent, en particulier deux muscles fessiers, le moyen et le petit, qui écartent la cuisse sur le côté et stabilisent la hanche pendant la marche. Une douleur ressentie à cet endroit vient d'ailleurs le plus souvent de leurs tendons, ces cordons qui relient le muscle à l'os, plutôt que de l'os lui-même.

Physiotherapy · Lateral hip pain

In brief

Greater trochanteric pain syndrome (GTPS) is the most common cause of lateral hip pain in adults; it is above all a compression tendinopathy of the gluteus medius and minimus tendons, and not an isolated bursitis (49.9 % tendinosis against 20.2 % bursitis on ultrasound). Predominantly female (female-to-male ratio of about 4:1) and of late onset (peak between 40 and 60 years), it presents with palpable trochanteric pain, aggravated when lying at night on the affected side. First-line management combines education and progressive abductor exercise: the LEAP trial shows a 78.5 % success rate at 52 weeks against 57.1 % for corticosteroid injection.

Clinical synthesis based on LEAP 2018, recent systematic reviews (Bremer 2025, Harding 2024) and reference reviews (Grimaldi & Fearon 2015, Speers 2017) on gluteus medius and minimus tendinopathy.

Clinical diagnosis Education + exercise Shockwave therapy / PRP Evidence-based
10-25%
Lifetime prevalence
Segal 2007 · cohort n=3026
4:1
Female-to-male ratio
Fearon 2013 · BJSM
78.5%
Success of education + exercise at 52 wk.
LEAP / Mellor 2018 · BMJ k1662

Clinical synthesis

  • Greater trochanteric pain syndrome (GTPS) is above all a compression tendinopathy of the gluteus medius and minimus tendons, not an isolated bursitis: in 877 patients examined by ultrasound, Long 2013 found 49.9 % tendinosis vs only 20.2 % bursitis, which was almost never isolated.
  • A predominantly female condition with a late onset: F:M ratio of around 4:1, peak between 40 and 60 years (Fearon 2013, Segal 2007). Established risk factors: high BMI, associated low back pain, ipsilateral hip osteoarthritis, hip abductor weakness (Allison 2016).
  • The diagnosis is clinical : lateral pain over the greater trochanter reproduced by palpation, aggravated when lying at night on the affected side, by prolonged single-leg stance, uphill walking and stairs.
  • Clinical tests: palpation of the gluteal tendon followed by resisted abduction (when both are positive, they raise the probability of GTPS from 59 % to 96 %; when both are negative, they lower it to 14 %; JOSPT 2024 meta-analysis, very low to moderate certainty), Single Leg Stance at 30 seconds (100 % specificity in 65 patients, MRI as the reference, Grimaldi 2017), FADER (Flexion-Adduction-External Rotation).
  • Imaging (MRI or ultrasound) is not recommended as a first-line investigation : tendon abnormalities are very common in asymptomatic people, particularly with age (weak correlation between imaging and symptoms).
  • First line, moderate level of evidence : patient education (avoiding compression) + progressive abductor exercise. The LEAP trial (Mellor 2018) shows a 78.5 % success rate at 52 weeks vs 57.1 % for corticosteroid injection.
  • The Bremer 2025 systematic review (Clinical Rehabilitation, without meta-analysis) cautiously recommends education with graded exercise as the core approach: a medium effect in the short term, small in the medium and long term, against minimal intervention. Shockwave therapy (ESWT) as second line for resistant cases, on conflicting evidence (Harding 2024, Rhim 2024).
  • PRP did better than corticosteroid injection at 12 and 24 weeks (Fitzpatrick 2019, AJSM), but two placebo-controlled trials find no difference (Thompson 2019; Atchia 2025, JBJS): its own efficacy is not established. Endoscopic surgery is only to be discussed as a last resort, on individual criteria (ISHA 2022 consensus).
  • Core education: avoid crossing the legs, do not slump onto one hip when standing on one leg, pillow between the knees at night, avoid low seats (knees higher than the hips).
  • GTPS can mimic L5 radiculopathy (abductor weakness, radiating lateral pain) or meralgia paraesthetica: a systematic neurological examination remains essential.
  • Return to impact activities must be criteria-based (strength, motor control, 30 s Trendelenburg test), with load progressing according to tolerance (next-day pain and stiffness included): the 10 % per week rule is only a guide, with no validated threshold.
  • Psychosocial factors (kinesiophobia, catastrophising) predict chronicity (Plinsinga 2020): identifying them early is non-negotiable.
  • Medication history : look for recent exposure to fluoroquinolones (ciprofloxacin, levofloxacin, ofloxacin) and any corticosteroid therapy given systemically or locally. Both increase the risk of tendinopathy and rupture, especially after 60 years, in weight-bearing tendons and when the two are combined.

Contents

  1. What are the fundamentals to know about greater trochanteric pain syndrome (GTPS)?
    1. How is this condition defined, who does it affect and what are the risk factors?
    2. What happens in the body and how does GTPS evolve naturally?
  2. How do you assess and diagnose GTPS with certainty?
    1. Which questions should you ask to understand the patient and their history?
    2. Which clinical tests should you perform and which other conditions need to be ruled out?
    3. Should patients with GTPS be classified, and for what benefit?
  3. What are the most effective treatment strategies for GTPS?
    1. Where do you start? What is the recommended hierarchy of interventions?
    2. What is the role of exercise, and is there a superior approach?
    3. Manual therapy, shockwave therapy, injections: how effective are they really?
    4. Beyond the physical: how do you educate the patient and address psychological factors?
  4. How can you ensure lasting recovery and prevent recurrences of GTPS?
    1. How do you make the patient an active participant in their recovery through self-management?
    2. When and how should a safe return to sport and activities be planned?
  5. Women > 40 years: why is GTPS a sex-specific condition and what are the clinical implications?
    1. Pelvic anatomy and biomechanics: why are women more exposed?
    2. Menopause, oestrogens and tendon health: an unfavourable cocktail?
    3. How do you stratify risk and adapt management?
  6. What do concrete clinical cases teach us about GTPS?
    1. Analysis of a “classic” case: from assessment to resolution.
    2. The diagnostic challenge: when GTPS mimics another condition.
    3. Study of a complex case: the operated tendon tear.
  7. How do you apply these recommendations concretely in your practice?
    1. When, and to which other healthcare professionals, should you refer?
    2. How do you measure outcomes and overcome barriers to implementation?

1. What are the fundamentals to know about greater trochanteric pain syndrome (GTPS)?

In this chapter: contemporary definition (Long 2013, Grimaldi 2015), epidemiology (Segal 2007, Lievense 2005), consolidated risk factors (Allison 2016, Fearon 2013), compression pathophysiology (iliotibial band, tendon-trochanter impingement) and natural history.

The condition known as Greater Trochanteric Pain Syndrome, abbreviated GTPS, is the most common cause of lateral hip pain in adults.¹ Long known as “trochanteric bursitis”, it is now understood as a compression tendinopathy of the gluteus medius and minimus tendons at their insertion on the greater trochanter, with bursitis being only a secondary and inconsistent finding.²

1.1. How is this condition defined, who does it affect and what are the risk factors?

GTPS is defined by pain reproducible on palpation of the greater trochanter, often associated with lateral hip pain aggravated by positions or activities involving relative hip adduction: lying on the affected side at night, prolonged single-leg stance, uphill walking or descending stairs.³ This clinical presentation is now consensually attributed to a degenerative, non-inflammatory tendinopathy of the gluteal muscles, and not to primary bursal inflammation.²

Among 877 patients examined by ultrasound for trochanteric pain, Long et al. (AJR 2013) found gluteal tendinosis in 49.9 % of cases, against only 20.2 % for bursitis, which was almost never isolated. The term “trochanteric bursitis” is therefore misleading in most cases.

Epidemiology 📊 :

  • Lifetime prevalence : 10 to 25 % of the general population has had at least one episode (reviews based on the Segal 2007 and Lievense 2005 cohorts).⁴⁻⁵
  • Incidence in primary care : 1.8 patients per 1,000 per year (retrospective cohort Lievense 2005, n = 164, mean age 55 years, 80 % women).⁵
  • Female-to-male ratio ≈ 4:1 (Fearon 2013, Speers 2017, Grimaldi 2015) with a peak incidence between 40 and 60 years, particularly marked after the menopause.¹⁻³
10-25%Lifetime prevalence
4:1Female-to-male ratio
49.9%Gluteal tendinosis on ultrasound (Long 2013)
1.8/1000/yearPrimary care incidence (Lievense 2005)

📊 GTPS: what is actually found on imaging?

Distribution of abnormalities in 877 consecutive patients (Long et al., AJR 2013)

Long 2013: tendinosis predominant, bursitis a minority 50% 40% 30% 20% 10% 0% 49.9 % Tendinosis gluteus medius + minimus 28.5 % IT band thickened 20.2 % Bursitis rarely isolated 0.5 % Tendon tear

Source: Long SS, Surrey DE, Nazarian LN. AJR Am J Roentgenol. 2013;201(5):1083-1086. Clinical implication : treatment focused on the anti-inflammatory management of the bursa is inappropriate in 80 % of cases.

Established risk factors :

  • High BMI : one of the strongest factors; markedly increased risk in overweight and obese people (Segal 2007).⁴
  • Female sex and age between 40 and 60 years, with post-menopausal exacerbation (Fearon 2013, Speers 2017).¹⁻³
  • Concomitant low back pain : association documented by several cohorts; the prevalence of GTPS reaches 20 to 35 % in patients referred for lumbar spine surgery (Tortolani 2002).⁶
  • Ipsilateral osteoarthritis (hip or knee) (Segal 2007).⁴
  • Hip abductor weakness : Allison 2016 (MSSE) demonstrates, compared with asymptomatic controls, a significant reduction in isometric abductor strength on the symptomatic side AND on the contralateral side.⁷
  • Increased pelvic width and female Q angle (biomechanics): favour relative adduction and tendon compression.²

🚩 Red flags in lateral hip pain

  • Severe non-mechanical night pain or progressive pain at rest → suspected neoplasm (bone metastasis, lymphoma), infection
  • Recent history of cancer (breast, prostate, lung, kidney, thyroid, melanoma) → metastatic work-up before any management
  • Fever, raised inflammatory markers, night sweats, unexplained weight loss → look for bone infection, septic arthritis, neoplasia
  • Recent high-energy trauma or sudden pain with loss of function in older / osteoporotic people → femoral neck fracture or trochanteric stress fracture
  • Progressive neurological deficit (weakness, L4-S1 dermatomal dysaesthesia, cauda equina) → serious spinal pathology
  • Deep swelling, mass asymmetry on inspection / palpation → MRI work-up + orthopaedic referral
  • Complete failure of well-conducted conservative treatment ≥ 6 months → look for a complete tendon tear (MRI), associated joint pathology

⚠️ Any red flag → rapid medical referral (general practitioner, emergency department, rheumatology or orthopaedic surgery) before physiotherapy management.

1.2. What happens in the body and how does GTPS evolve naturally?

The central pathophysiology of GTPS is tendon compression 🔬: the gluteus medius and minimus tendons are compressed against the lateral and posterosuperior facet of the greater trochanter, mainly by the iliotibial band that covers them.²·⁸ This compression is maximal when the hip is in relative adduction (that is, whenever the centre of gravity of the femoral head is displaced medially relative to the weight-bearing foot: prolonged single-leg stance, standing with the weight shifted onto one hip, lying on the affected side without a pillow, or crossed legs when seated).²·³

🦵 Mechanism: why relative adduction crushes the gluteal tendons

At-risk positions vs protective positions (“compressive load” concept, Grimaldi 2015)

Tendon compression according to hip position ❌ Relative adduction HIGH COMPRESSION crossed legs · weight on one hip · side-lying → trochanteric pain reproduced ⚠ Neutral MODERATE COMPRESSION standing, symmetrical two-leg support → reduced symptoms ✅ Slight abduction DECOMPRESSION pillow between the knees · uncrossed legs → protective night-time position

Adapted from Grimaldi A & Fearon A. JOSPT. 2015;45(11):910-922. The fundamental biomechanical lever of treatment: moving the patient’s positions towards tendon decompression.

Under the effect of this chronic compression, the tendon develops degenerative changes described by the tendinopathy continuum model of Cook & Purdam (BJSM 2009):⁸

  1. Tendinopathy in its reactive form (acute response to overload, non-inflammatory, reversible thickening);
  2. Tendon “remodelled” (disrepair): disorganised attempt at healing;
  3. Tendinopathy in its degenerative form: advanced structural changes with loss of collagen fibre organisation, neovascularisation and sensory hyperinnervation contributing to pain.

The natural course is not systematically favourable. The historical cohort Lievense 2005 (BJGP) following 164 patients in primary care showed that about 29 % of patients reported complete recovery at 5 years, whereas 36 % kept or worsened their symptoms.⁵ A cohort 11 years later confirmed this potentially chronic nature of GTPS, fully justifying active management. In persistent cases, Plinsinga 2020 (Pain Med) demonstrated the presence of a deficit in central pain modulation in patients with chronic GTPS vs pain-free controls, an additional argument for integrating a biopsychosocial approach as soon as symptoms persist beyond a few weeks.⁹

  • GTPS is above all a compression tendinopathy of the gluteus medius and minimus, and not an isolated bursitis (Long 2013: 49.9 % tendinosis vs 20.2 % bursitis).
  • A predominantly female condition with a late onset: F:M ratio ≈ 4:1, peak between 40 and 60 years. Key risk factors: high BMI, associated low back pain, hip osteoarthritis, abductor weakness.
  • Mechanism = compression of the tendons by the iliotibial band, aggravated by relative hip adduction positions.
  • Potentially chronic course: 36 % persistent symptoms at 5 years without active treatment. Central sensitisation may develop in refractory cases.
Bibliography - Chapter 1
  1. Speers CJ, Bhogal GS. Greater trochanteric pain syndrome: a review of diagnosis and management in general practice. Br J Gen Pract. 2017;67(663):479-480. PMID 28963433.
  2. Grimaldi A, Fearon A. Gluteal Tendinopathy: Integrating Pathomechanics and Clinical Features in Its Management. J Orthop Sports Phys Ther. 2015;45(11):910-922. PMID 26381486. doi:10.2519/jospt.2015.5829.
  3. Fearon AM, Scarvell JM, Neeman T, Cook JL, Cormick W, Smith PN. Greater trochanteric pain syndrome: defining the clinical syndrome. Br J Sports Med. 2013;47(10):649-653. PMID 22983121.
  4. Segal NA, Felson DT, Torner JC, et al. Greater trochanteric pain syndrome: epidemiology and associated factors. Arch Phys Med Rehabil. 2007;88(8):988-992. PMID 17678660.
  5. Lievense A, Bierma-Zeinstra S, Schouten B, Bohnen A, Verhaar J, Koes B. Prognosis of trochanteric pain in primary care. Br J Gen Pract. 2005;55(512):199-204. PMID 15808035.
  6. Tortolani PJ, Carbone JJ, Quartararo LG. Greater trochanteric pain syndrome in patients referred to orthopedic spine specialists. Spine J. 2002;2(4):251-254. PMID 14589475.
  7. Allison K, Vicenzino B, Wrigley TV, Grimaldi A, Hodges PW, Bennell KL. Hip Abductor Muscle Weakness in Individuals with Gluteal Tendinopathy. Med Sci Sports Exerc. 2016;48(3):346-352. PMID 26418561.
  8. Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med. 2009;43(6):409-416. PMID 18812414.
  9. Plinsinga ML, Coombes BK, Mellor R, Vicenzino B. Individuals with Persistent Greater Trochanteric Pain Syndrome Exhibit Impaired Pain Modulation, as well as Poorer Physical and Psychological Health, Compared with Pain-Free Individuals: A Cross-Sectional Study. Pain Med. 2020;21(11):2964-2974. PMID 32232468.
  10. Long SS, Surrey DE, Nazarian LN. Sonography of greater trochanteric pain syndrome and the rarity of primary bursitis. AJR Am J Roentgenol. 2013;201(5):1083-1086. AJR doi:10.2214/AJR.12.10038.
This topic is covered by a Physio Learning course, eligible for DPC and FIFPL funding.See the course

2. How do you assess and diagnose GTPS with certainty?

In this chapter: key history (night pain lying on the affected side, single-leg stance), clinical tests (palpation then resisted abduction, Single Leg Stance, FADER), rigorous differential diagnosis (L5 radiculopathy, hip osteoarthritis, FAI, meralgia), the limited place of imaging and the contribution of stage-based classification.

The diagnosis of GTPS is essentially clinical. It rests on a cluster of convergent findings from the history and physical examination.¹ Imaging (MRI or ultrasound) adds modest value as a first-line investigation and carries the major risk of over-interpretation : the prevalence of asymptomatic tendon abnormalities on gluteal MRI increases with age, making a diagnosis of “imaging abnormality” a classic trap.²

2.1. Which questions should you ask to understand the patient and their history? 🧐

The history, the most discriminating step, must seek to reconstruct a pathognomonic clinical pattern :

  • “Does your pain wake you at night, especially when you sleep on the painful side?” A positive answer in the majority of patients with GTPS.¹
  • “Which activities provoke or aggravate the pain?” Typically: prolonged walking, going up and down stairs, single-leg stance (putting on trousers), sitting with the legs crossed or on a low seat.³
  • “Have you changed your activity habits recently?” A rapid increase in walking volume, recent weight gain, a return to sport: these are typical contexts.¹
  • “Where exactly is the pain?” Typically the greater trochanter, sometimes radiating along the lateral aspect of the thigh without clearly extending below the knee (a discriminating sign vs L5 radiculopathy).⁴
  • “Do you have associated low back pain?” A common comorbidity, but essential to distinguish (see the differential below).

2.2. Which clinical tests should you perform and which other conditions need to be ruled out? 🤸

Coronal pelvic MRI: labels directly on the image, normal gluteus medius tendon on the right, tendinous rupture with fatty atrophy on the left, greater trochanteric pain syndrome.

MRICoronal pelvic MRI: labels directly on the image, normal gluteus medius tendon on the right, tendinous rupture with fatty atrophy on the left, greater trochanteric pain syndrome.

Source : Kaltenborn et al., PLoS ONE, 2014, figure 3 · CC BY

Common clinical tests have limited validity: in a cohort of 65 patients, one in three with tendinopathy on MRI had a negative clinical examination.⁷ A diagnostic accuracy meta-analysis (Kinsella, JOSPT 2024: 6 studies, 272 participants, very low to moderate certainty) proposes a simple sequence: palpation of the gluteal tendon, then resisted abduction. In patients consulting for lateral hip pain, with a mean pre-test probability of 59 %, two positive tests raise it to 96 % and two negative tests lower it to 14 %.¹⁰ However, no test or group of tests identifies the structure affected.¹¹ The best-studied tests:

TestDescriptionPerformanceLevel of evidence
Direct palpation of the greater trochanterReproduction of the familiar pain by pressure on the posterosuperior facetHigh sensitivity but low specificity (palpation is also tender in many asymptomatic people)Moderate
Single Leg Stance (30 s)The patient stands on the affected leg for 30 s; the test is positive if the lateral pain is reproducedSpecificity 100 % (positive likelihood ratio of about 12) in 65 patients consulting for lateral pain, MRI as the reference (Grimaldi 2017); sens. 100 % / spec. 97.3 % in a series of 17 patients with refractory GTPS compared with controls without hip pain (Lequesne 2008)Moderate (limited samples)
FADER (Flexion-Adduction-External Rotation)Patient supine: hip flexed to 90°, maximal adduction, external rotationStudied in the Grimaldi 2017 cohort (65 patients, MRI as the reference), in which pain on 30 s single-leg stance is the most specific testModerate
Hip abduction resistance test in side-lyingPatient side-lying, abduction against manual resistanceAfter palpation of the gluteal tendon: two positive tests raise the probability from 59 % to 96 %, two negative tests lower it to 14 % (Kinsella 2024)Very low to moderate
Modified Trendelenburg (30 s)Pelvic drop on the non-weight-bearing side ≥ 2 cm during 30 s single-leg stanceIndicator of functional abductor weaknessLow (indirect test)

🧭 Diagnostic decision tree for lateral hip pain

From clinical suspicion to confirmation: after Grimaldi 2015 (Sports Med) and Grimaldi 2017 (BJSM)

GTPS decision tree Lateral hip pain localised over the greater trochanter RED FLAGS? cancer, fever, severe night pain, neurological deficit, suspected fracture → DOCTOR imaging + work-up CLINICAL EXAMINATION Palpation of the gluteal tendon → resisted abduction + Single Leg Stance 30 s, FADER, compatible history DIFFERENTIAL DIAGNOSIS RULED OUT? L5 radiculopathy (Slump, reflexes, dermatome) · Hip osteoarthritis (FADIR, range of motion) · FAI · Meralgia paraesthetica · Sacroiliac joint DIAGNOSIS: GTPS → Imaging ONLY if conservative management fails ≥ 6-8 weeks OR red flags, OR suspected complete tear

Algorithm synthesised from Grimaldi 2015 (Sports Med), Grimaldi 2017 (BJSM) and current practice: imaging has no place as a first-line investigation in patients without a red flag.

Mandatory differential diagnosis ⚖️ :

  • L4-L5 radiculopathy : pain along the lateral aspect of the thigh that may extend down to the foot, radicular motor deficit, dermatomal dysaesthesia, positive neurodynamic signs (Slump, SLR). Several reports describe a false radiculopathy in GTPS, or the reverse.⁴
  • Hip osteoarthritis : rather groin pain, morning stiffness, limited range of motion (especially internal rotation), positive FADIR test.⁶
  • Femoroacetabular impingement (FAI) : young athlete, predominantly anterior pain, positive FADIR.
  • Meralgia paraesthetica : neurological symptoms such as burning or paraesthesia over the territory of the lateral femoral cutaneous nerve (anterolateral aspect of the thigh); Tinel test over the anterior superior iliac spine sometimes positive.⁷
  • Piriformis syndrome or sacroiliac pathology: posterior buttock pain rather than lateral.
  • Proximal hamstring tendinopathy : low buttock pain, on prolonged sitting.
  • Femoral neck stress fracture or trochanteric stress fracture (endurance athlete, woman with RED-s, older osteoporotic person): progressive pain of increasing intensity, sometimes sudden loss of function.

2.3. Should patients with GTPS be classified, and for what benefit? 🎯

A functional classification is useful to dose the therapeutic load. The Cook & Purdam tendinopathy continuum model (BJSM 2009, revisited 2016) remains the operational reference:⁸

  1. Reactive tendinopathy (often young adults, recent onset < 6 wk.): pain of rapid onset after overload. Management favours temporary load reduction and pain-free isometric exercises. Early heavy strengthening would be harmful.
  2. Remodelled tendon (3-6 months): intermediate phase; progressive introduction of isotonic exercises without high compressive loads.
  3. Degenerative tendinopathy (often > 6 months, older person): an approach using progressive heavy strengthening (HSR: Heavy Slow Resistance) to improve functional capacity, even if the tendon structure is not restored.
  • GTPS diagnosis = clinical cluster : palpation of the gluteal tendon then resisted abduction (both positive: diagnosis very likely; both negative: unlikely), highly specific Single Leg Stance 30 s, FADER, compatible history.
  • Imaging is of no use as a first-line investigation except for red flags or failed conservative treatment. Major risk: over-interpretation of asymptomatic abnormalities.
  • Non-negotiable differential diagnosis: L5 radiculopathy, hip osteoarthritis, FAI, meralgia paraesthetica, stress fracture.
  • Stage-based classification (reactive / remodelled / degenerative) to dose rehabilitation : isometric in the acute phase, HSR in the chronic phase.
Bibliography - Chapter 2
  1. Grimaldi A, Mellor R, Hodges P, Bennell K, Wajswelner H, Vicenzino B. Gluteal Tendinopathy: A Review of Mechanisms, Assessment and Management. Sports Med. 2015;45(8):1107-1119. PMID 25969366.
  2. Long SS, Surrey DE, Nazarian LN. Sonography of greater trochanteric pain syndrome and the rarity of primary bursitis. AJR Am J Roentgenol. 2013;201(5):1083-1086. AJR.
  3. Speers CJ, Bhogal GS. Greater trochanteric pain syndrome: a review of diagnosis and management in general practice. Br J Gen Pract. 2017;67(663):479-480. PMID 28963433.
  4. Tortolani PJ, Carbone JJ, Quartararo LG. Greater trochanteric pain syndrome in patients referred to orthopedic spine specialists. Spine J. 2002;2(4):251-254. PMID 14589475.
  5. Lequesne M, Mathieu P, Vuillemin-Bodaghi V, Bard H, Djian P. Gluteal tendinopathy in refractory greater trochanter pain syndrome: diagnostic value of two clinical tests. Arthritis Rheum. 2008;59(2):241-246. PMID 18240186.
  6. Fearon AM, Scarvell JM, Neeman T, Cook JL, Cormick W, Smith PN. Greater trochanteric pain syndrome: defining the clinical syndrome. Br J Sports Med. 2013;47(10):649-653. PMID 22983121.
  7. Grimaldi A, Mellor R, Nicolson PJA, Hodges P, Bennell K, Vicenzino B. Utility of clinical tests to diagnose MRI-confirmed gluteal tendinopathy in patients presenting with lateral hip pain. Br J Sports Med. 2017;51(6):519-524. PMID 27633027.
  8. Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med. 2009;43(6):409-416. PMID 18812414.
  9. Cook JL, Rio E, Purdam CR, Docking SI. Revisiting the continuum model of tendinopathy: what is its merit in clinical practice and research? Br J Sports Med. 2016;50(19):1187-1191. PMID 27127294.
  10. Kinsella R, Semciw AI, Hawke LJ, Stoney J, Choong PFM, Dowsey MM. Diagnostic Accuracy of Clinical Tests for Assessing Greater Trochanteric Pain Syndrome: A Systematic Review With Meta-analysis. J Orthop Sports Phys Ther. 2024;54(1):26-49. PMID 37561820.
  11. Disantis A, Andrade AJ, Baillou A, et al. The 2022 International Society for Hip Preservation (ISHA) physiotherapy agreement on assessment and treatment of greater trochanteric pain syndrome (GTPS): an international consensus statement. J Hip Preserv Surg. 2023;10(1):48-56. PMID 37275836.

3. What are the most effective treatment strategies for GTPS?

In this chapter: evidence-based treatment hierarchy (LEAP 2018, Bremer 2025), superiority of education + progressive exercise over corticosteroid injections, the place of shockwave therapy (Harding 2024, Rhim 2024: conflicting evidence), PRP (Fitzpatrick 2019; two negative placebo-controlled trials) and endoscopic surgery as a last line.

The hierarchy of interventions for GTPS rests first on the LEAP trial (Mellor 2018, BMJ): education with progressive exercise does better than corticosteroid injection at 8 weeks, and at 52 weeks on global improvement, with no difference in pain intensity at one year. The Bremer 2025 systematic review (Clinical Rehabilitation) cautiously recommends it as the core of treatment.¹⁻²

3.1. Where do you start? What is the hierarchy of recommended interventions?

The consensus hierarchy (LEAP, Speers 2017, Grimaldi 2015, Bremer 2025):¹⁻⁴

  1. First line (always): education + graded exercise. High level of evidence.
  2. Second line for cases resistant at 8-12 weeks : extracorporeal shockwave therapy (ESWT), on conflicting evidence: Harding 2024 finds no significant difference against control;¹¹ Rhim 2024, in trials mostly at high risk of bias, finds lower pain at 2-4 months against other treatments.¹⁵
  3. Third line : corticosteroid injection, solely for short-term relief (≤ 6 weeks) while waiting for exercise to take over. Harmful effect on tendon integrity if repeated (Coombes 2010, Lancet).⁶
  4. Medical option under debate : PRP (platelet-rich plasma). Fitzpatrick 2019 (AJSM, randomised trial, n = 80) finds a better result than a corticosteroid injection at 12 and 24 weeks; beyond 3 months, the follow-up is an open-label extension in which patients who failed on corticosteroid could receive PRP.⁷ Two trials against a placebo injection find no difference (Thompson 2019; Atchia 2025, 79 patients, double-blind), and the authors of the second do not support its routine use;¹³,¹² a 2026 systematic review, with very heterogeneous trials, remains favourable.¹⁴ PRP’s own efficacy is therefore not established.
  5. Last line : surgery (endoscopic repair of the gluteal tendons, Walker-Santiago 2020).⁸ The ISHA international consensus (2022, modified Delphi bringing together physiotherapists and orthopaedic surgeons) did not reach agreement on criteria for surgery: the decision remains individual and may rely on a tear on imaging, failure of appropriate conservative management, a marked limp or an inability to abduct against gravity. The same panel recommends rehabilitation based on the impairments found on examination, and rehabilitation after any injection, corticosteroid or PRP.¹⁶

📊 LEAP trial: education + exercise vs corticosteroids vs “wait and see” at 52 wk.

% of patients reporting a perceived global improvement (n=204, multicentre RCT, Mellor 2018)

LEAP trial - clinical success at 52 weeks 100% 75% 50% 25% 0% 78.5 % Education + Exercise 14 sessions over 8 weeks 57.1 % Corticosteroid injection 1 ultrasound-guided injection 51.7 % Wait and see waiting without intervention

Source: Mellor R et al. BMJ. 2018;361:k1662. PMID 29720374. Success = “much better” or “completely recovered” on the GROC scale. Conclusion : at 52 weeks, more success than after injection (a 20-point difference, number needed to treat 4.9), with no difference in pain intensity.

3.2. What is the role of exercise, and is there a superior approach?

Exercise is not just one component of the treatment: it is its core. The Bremer 2025 systematic review (search up to August 2024, medium- to high-quality trials, without meta-analysis) finds moderate-strength evidence of a medium short-term effect on pain and function, small in the medium and long term, against minimal intervention, and cautiously recommends it as the core approach.² 💪

Exercise must respect the principle of optimal load : enough to stimulate tendon adaptation, not enough to irritate. “Tolerable pain at 24 h” rule: pain during exercise may reach 4/10 provided it does not increase within the following 24 h (Silbernagel, pain-monitoring model).

Structure of a typical programme (synthesis of Grimaldi 2015, Mellor 2018, Bremer 2025):

  1. Phase 1: Pain modulation and decompression (weeks 1-2) :
    • Education on managing compressive positions (see § self-management) absolute priority.
    • Abduction isometrics in supine (without compressive load): hold 30-45 s × 4-5 repetitions, 1-2 times/day.
    • Avoidance of prolonged adduction positions.
  2. Phase 2: Targeted isotonic strengthening (weeks 3-6) :
    • Single-leg bridge (progressing towards 20-30 quality repetitions);
    • Side-lying abduction without letting the thigh drop into adduction, with elastic band or light weight;
    • Modified “clam shell” without lateral compression;
    • Hip hike (hemipelvic lift) in controlled single-leg stance.
  3. Phase 3: Functional strengthening (weeks 6-12) :
    • Partial single-leg squat with control of pelvis-knee alignment;
    • Controlled step-ups and step-downs;
    • Progressive uphill walking;
    • Heavy Slow Resistance (HSR) with increasing load for degenerative patients.
  4. Phase 4: Return to specific activities (beyond 12 weeks) : running, sports, hiking (see chapter 4).

3.3. Manual therapy, shockwave therapy, injections: how effective are they really?

Coronal hip MRI before and after treatment: thickening of the gluteus medius tendon with intratendinous hyperintensity, arrow, visible reduction after autologous tenocyte injection.

MRICoronal hip MRI before and after treatment: thickening of the gluteus medius tendon with intratendinous hyperintensity, arrow, visible reduction after autologous tenocyte injection.

Source : Bucher et al., Orthopaedic Journal of Sports Medicine, 2017, figure 4 · CC BY-NC-ND

ModalityLevel of evidenceExpected effectPlace in practice
Education + graded exerciseModerate (LEAP, Bremer 2025)78.5 % success at 52 wk.1st line, essential
Shockwave therapy (ESWT)Conflicting (Harding 2024, Rhim 2024)Harding: no statistically significant difference in pain or function against control (12 studies, n = 1,121); moderate effect size for pain (Hedges’ g 0.71), small for function (0.20). Rhim: lower pain at 2-4 months against other treatments (8 trials, 754 patients, 7 at high risk of bias), functional gain at 6 months below the threshold of clinical relevance; focused shockwaves better than radial shockwaves2nd line if unsuccessful at 8-12 wk.
PRP (Platelet-Rich Plasma)Low, conflicting (Fitzpatrick 2019 against corticosteroids; Thompson 2019 and Atchia 2025 against placebo)Better than corticosteroids at 12 and 24 wk.; no difference against placebo in two trialsMedical option, its own efficacy not established
Corticosteroid injectionModerate (short term only)Clear improvement at 4-6 wk., loss of benefit at 12 wk., inferior to exercise at 52 wk.3rd line: transient relief
Dry needlingLow (Brennan 2017 non-inferiority)Non-inferiority vs corticosteroid in the short term in one RCTAdjunct option; limited evidence
Manual therapyLow (few specific RCTs)Useful for associated restrictions (lumbar spine, hip mobility)Adjunct to facilitate exercise
Oral NSAIDsLowShort-term symptomatic reliefCaution (tendinosis > tendinitis, anti-inflammatory bias)
Endoscopic surgeryModerate (Walker-Santiago 2020 SR)Good recovery at 2 years, complications > PRPLast resort or complete tear

📐 Hierarchy of interventions for GTPS (evidence and effect)

Horizontal pyramid (synthesis of Bremer 2025, Mellor 2018, Harding 2024)

GRADE levels of evidence by modality MODERATE ★★★ · MEDIUM EFFECT Education + graded exercise (LEAP 2018, Bremer 2025) 1st line MODERATE ★★★ · SMALL EFFECT Shockwave therapy (Harding, Rhim 2024: conflicting) · Short-term corticosteroids LOW ★★ PRP · Dry needling (Brennan 2017) · Manual therapy · NSAIDs · Passive VERY LOW ★ Mesenchymal stem cells · Sclerosing agents · Unvalidated therapies

GRADE = Grading of Recommendations Assessment, Development and Evaluation. Source: synthesis of the systematic reviews by Bremer 2025 (moderate-strength evidence for education with exercise and for short-term corticosteroids), Harding 2024 and Rhim 2024, and of the PRP trials. Endoscopic surgery remains a last line, on individual criteria (ISHA 2022).

3.4. Beyond the physical: how do you educate the patient and address psychological factors?

🧠 The biopsychosocial approach is non-negotiable for chronic GTPS. Plinsinga 2020 (Pain Med) showed that patients with persistent GTPS present:⁹

  • Impaired conditioned pain modulation (CPM) (a marker of central sensitisation).
  • Impaired psychological health (anxiety, depression, quality of life).
  • High catastrophising and kinesiophobia scores.

These factors are not merely consequences of pain: they are independent predictors of chronicity and treatment failure. Identifying yellow flags (Fear-Avoidance Beliefs Questionnaire, FABQ; Pain Catastrophizing Scale, PCS) at the start of management is as important as the physical assessment.

  • First line (moderate level of evidence) : patient education + progressive abductor exercise. LEAP 2018: 78.5 % success vs 57.1 % corticosteroids vs 51.7 % “wait and see” at 52 wk.
  • Hierarchy : exercise first; shockwave therapy and injections next, on conflicting evidence (corticosteroids: short term; PRP: own efficacy not established); surgery as a last resort.
  • Avoid compression : systematic education on the positions to avoid (crossed legs, standing with the weight shifted onto one hip, side-lying without a pillow).
  • Think biopsychosocial from the initial assessment: kinesiophobia and catastrophising predict failure (Plinsinga 2020).
Bibliography - Chapter 3
  1. Mellor R, Bennell K, Grimaldi A, et al. Education plus exercise versus corticosteroid injection use versus a wait and see approach on global outcome and pain from gluteal tendinopathy: prospective, single blinded, randomised clinical trial (LEAP). BMJ. 2018;361:k1662. PMID 29720374.
  2. Bremer T, Nicklen P, Fearon A, Morrissey D. The efficacy of gluteal tendinopathy treatments: A systematic review. Clin Rehabil. 2025. doi:10.1177/02692155251327298.
  3. Speers CJ, Bhogal GS. Greater trochanteric pain syndrome: a review of diagnosis and management in general practice. Br J Gen Pract. 2017;67(663):479-480. PMID 28963433.
  4. Grimaldi A, Mellor R, Hodges P, Bennell K, Wajswelner H, Vicenzino B. Gluteal Tendinopathy: A Review of Mechanisms, Assessment and Management. Sports Med. 2015;45(8):1107-1119. PMID 25969366.
  5. Mani-Babu S, Morrissey D, Waugh C, et al. The effectiveness of extracorporeal shock wave therapy in lower limb tendinopathy: a systematic review. Am J Sports Med. 2015;43(3):752-761. PMID 24817008.
  6. Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010;376(9754):1751-1767. PMID 20970844.
  7. Fitzpatrick J, Bulsara MK, O'Donnell J, Zheng MH. Leucocyte-Rich Platelet-Rich Plasma Treatment of Gluteus Medius and Minimus Tendinopathy: A Double-Blind Randomized Controlled Trial With 2-Year Follow-up. Am J Sports Med. 2019;47(5):1130-1137. PMID 30840831.
  8. Walker-Santiago R, Wojnowski NM, Lall AC, et al. Platelet-Rich Plasma Versus Surgery for the Management of Recalcitrant Greater Trochanteric Pain Syndrome: A Systematic Review. Arthroscopy. 2020;36(3):875-888. PMID 31882270.
  9. Plinsinga ML, Coombes BK, Mellor R, Vicenzino B. Individuals with Persistent Greater Trochanteric Pain Syndrome Exhibit Impaired Pain Modulation, as well as Poorer Physical and Psychological Health. Pain Med. 2020;21(11):2964-2974. PMID 32232468.
  10. Brennan KL, Allen BC, Maldonado YM. Dry Needling Versus Cortisone Injection in the Treatment of Greater Trochanteric Pain Syndrome: A Noninferiority Randomized Clinical Trial. J Orthop Sports Phys Ther. 2017;47(4):232-239. PMID 28257614.
  11. Harding D, Cameron L, Monga A, Winter S. Is shockwave therapy effective in the management of greater trochanteric pain syndrome? A systematic review and meta-analysis. Musculoskeletal Care. 2024;22(2):e1892. doi:10.1002/msc.1892. PMID 38777616.
  12. Atchia I, Ali M, Oderuth E, Holleyman R, Malviya A. Efficacy of Platelet-Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome: A Double-Blinded Randomized Controlled Trial. J Bone Joint Surg Am. 2025;107(5):444-451. PMID 39804899.
  13. Thompson G, Pearson JF. No attributable effects of PRP on greater trochanteric pain syndrome. N Z Med J. 2019;132(1507):22-32. PMID 31830014.
  14. Kuhns BD, Becker N, Reyes-Cordova A, et al. Improved Outcomes With Platelet-Rich Plasma for Treating Extra-articular Hip Pathology Especially Greater Trochanteric Pain Syndrome and Hamstring Injury: A Systematic Review of Randomized Controlled Trials. Arthroscopy. 2026;42(1):310-325. PMID 41838530.
  15. Rhim HC, Shin J, Beling A, et al. Extracorporeal Shockwave Therapy for Greater Trochanteric Pain Syndrome: A Systematic Review with Meta-Analysis of Randomized Clinical Trials. JBJS Rev. 2024;12(8). PMID 39297780.
  16. Disantis A, Andrade AJ, Baillou A, et al. The 2022 International Society for Hip Preservation (ISHA) physiotherapy agreement on assessment and treatment of greater trochanteric pain syndrome (GTPS): an international consensus statement. J Hip Preserv Surg. 2023;10(1):48-56. PMID 37275836.

4. How can you ensure lasting recovery and prevent recurrences of GTPS?

In this chapter: self-management as a cornerstone (LEAP 2018), management of compressive loads in daily life (Grimaldi 2015), criteria-based return to activity (strength, motor control), load progression paced by tolerance and long-term maintenance.

GTPS management does not stop when the initial pain resolves. An effective strategy rests on a long-term approach aimed at preventing recurrences and ensuring a lasting return to meaningful activities.¹ Two pillars: patient autonomy through self-management and criteria-based planning of the return to activities.

4.1. How do you make the patient an active participant in their recovery through self-management?

Therapeutic education is superior to passive approaches in the long term (LEAP: 77 % success “education+exercise” vs 58 % “injection”, at 52 wk.).² The patient must acquire 4 key skills:

  1. Managing compressive loads in daily life 🧑‍🏫 :
    • Do not cross the legs when seated;
    • Avoid low seats (knees higher than the hips);
    • Standing: spread the weight over both legs, avoid prolonged “hanging on one hip”;
    • Sleep: prefer lying on the non-painful side with a pillow between the knees; avoid side-lying on the affected side.³
  2. Pain monitoring ⚖️: a simple rule, applicable autonomously: pain during an activity may reach 4-5/10 if it does not worsen within the following 24 h (adapted Silbernagel model).⁴
  3. Adherence to the home programme 💪: consistency > intensity. A brief daily session is worth more than a long weekly session that is missed.
  4. Identifying psychosocial factors 🧠: recognising one’s own catastrophic thoughts or avoidance; open dialogue with the clinician about fears related to movement.

🏠 8 key validated self-management actions (synthesis of Grimaldi 2015, Mellor 2018)

To be taught systematically from the first session

GTPS self-management - 8 key actions ✅ 1. Pillow between the knees Side-lying, never on the painful side at night ✅ 2. Legs uncrossed When seated (desk, meals, transport) ✅ 3. Knees ≤ hips Avoid low seats, deep armchairs. Cushion if necessary ✅ 4. Two-leg support Standing: equal weight on both legs, never “hanging on one hip” ✅ 5. Controlled stairs No pelvic drop on the opposite side (pelvis-knee alignment) ✅ 6. Progressive walking Duration increased according to tolerance. Avoid long walks at first ✅ 7. Daily strengthening Home programme: 10-15 min/day according to a personalised protocol ✅ 8. 24-hour pain monitoring Pain 4/10 OK if no worse at H+24. Otherwise: reduce the load

Adapted from Grimaldi A. JOSPT 2015 and the LEAP protocol (Mellor 2018). To be handed out as a patient roadmap.

4.2. When and how should a safe return to sport and activities be planned? 🏃

Return to impact activities must be criteria-based, not calendar-based.⁵ The validated hierarchy:

  1. Restoration of pain-free daily function : walking 30 min, pain-free stair climbing, prolonged standing tolerated.
  2. Strength and motor control criteria :
    • 20-30 repetitions of single-leg bridge without compensation;
    • 30 s Trendelenburg test without a pelvic drop ≥ 2 cm;
    • Isometric abductor strength symmetry ≥ 90 % (dynamometer measurement).
  3. Progressive reintroduction of specific loads (example for a runner):
    • Weeks 1-2: alternating walk/run programme (1 min running + 4 min walking × 5);
    • Weeks 3-6: increase in volume according to tolerance (pain during, after and the day after the run), avoiding excessive and rapid increases in load;⁶ in a cohort of 5,205 runners, the week-to-week increase is not linked to overuse injuries, but the session that exceeds the longest run of the previous 30 days by more than 10 % is (observational study);⁹
    • Weeks 6+: introduction of only one new parameter at a time (hills, speed, surface).
  4. Long-term maintenance : 1-2 gluteal strengthening sessions per week for life in at-risk patients (postmenopausal woman, recreational runner).

🚩 Red flags specific to return to activity

  • Night waking with pain after resuming activity → immediate load reduction
  • Pain increase > 4/10 persisting at 24 h post-exercise → adapt the programme
  • Onset of a limp or a persistent Trendelenburg sign → resume analytical exercises
  • Pain extending below the knee (L5-S1 radiation) → re-evaluate for a radicular differential diagnosis
  • Sensation of a “snap” or sudden loss of function → suspected tendon rupture → MRI
  • For lasting recovery from GTPS, the approach must be active and patient-centred.
  • ✅ Education is the key : avoid compression positions (crossed legs, standing with the weight shifted onto one hip, lying on the affected side without a pillow).
  • 🏋️ Exercise is the treatment : progressive and consistent strengthening of the abductors.
  • 📈 Criteria-based graded return : progression paced by tolerance; the 10 % per week rule is only a guide, with no validated threshold.
  • 🧠 Self-management is the ultimate goal : the patient becomes an expert in their condition.
Bibliography - Chapter 4
  1. Grimaldi A, Mellor R, Hodges P, Bennell K, Wajswelner H, Vicenzino B. Gluteal Tendinopathy: A Review of Mechanisms, Assessment and Management. Sports Med. 2015;45(8):1107-1119. PMID 25969366.
  2. Mellor R, Bennell K, Grimaldi A, et al. LEAP trial. BMJ. 2018;361:k1662. PMID 29720374.
  3. Speers CJ, Bhogal GS. Greater trochanteric pain syndrome. Br J Gen Pract. 2017;67(663):479-480. PMID 28963433.
  4. Silbernagel KG, Thomeé R, Eriksson BI, Karlsson J. Continued sports activity, using a pain-monitoring model, during rehabilitation in patients with Achilles tendinopathy: a randomized controlled study. Am J Sports Med. 2007;35(6):897-906. PMID 17307888.
  5. Bremer T, Nicklen P, Fearon A, Morrissey D. The efficacy of gluteal tendinopathy treatments: A systematic review. Clin Rehabil. 2025. doi:10.1177/02692155251327298.
  6. Gabbett TJ. The training-injury prevention paradox: should athletes be training smarter and harder? Br J Sports Med. 2016;50(5):273-280. PMID 26758673.
  7. Plinsinga ML, Coombes BK, Mellor R, Vicenzino B. Individuals with Persistent GTPS Exhibit Impaired Pain Modulation. Pain Med. 2020;21(11):2964-2974. PMID 32232468.
  8. Allison K, Vicenzino B, Wrigley TV, Grimaldi A, Hodges PW, Bennell KL. Hip Abductor Muscle Weakness in Individuals with Gluteal Tendinopathy. Med Sci Sports Exerc. 2016;48(3):346-352. PMID 26418561.
  9. Schuster Brandt Frandsen J, Hulme A, Parner ET, et al. How much running is too much? Identifying high-risk running sessions in a 5200-person cohort study. Br J Sports Med. 2025;59(17):1203-1210. PMID 40623829.

5. Women > 40 years: why is GTPS a sex-specific condition?

In this chapter: female over-representation (4:1) explained by pelvic anatomy (Birnbaum 2004), the hormonal role of the menopause in tendon health, identification of at-risk subgroups (sedentary vs masters athletes), clinical stratification tool and practical adaptation of the programme.

GTPS is one of the few musculoskeletal tendinopathies to show such a marked sex and hormonal bias : 4 women for 1 man, and a peak incidence overlapping the menopausal transition.¹ Understanding this bias is not an epidemiological curiosity: it is the key to stratifying risk, personalising rehabilitation and anticipating chronicity.

5.1. Pelvic anatomy and biomechanics: why are women more exposed?

Several female biomechanical features converge to increase compressive stresses on the gluteus medius and minimus tendons at the trochanteric insertion:²⁻³

  • Wider pelvis : the bi-trochanteric distance is on average 5 to 10 % greater in women, which increases the lever arm in relative adduction and the tension on the iliotibial band overlying the gluteal tendons.²
  • Increased Q angle (quadriceps) : more marked dynamic knee valgus during walking, squatting and running, contributing to compressive hip adduction-internal rotation for the lateral gluteals.
  • Femoral neck geometry : mean femoral anteversion 4 to 6° greater, altering the path of the fascia lata over the greater trochanter.
  • Relative abductor weakness : the Allison 2016 cohort (MSSE) demonstrated significantly lower isometric abductor strength in women with GTPS vs asymptomatic controls, even on the non-painful side (suggesting a baseline vulnerability before the condition develops).⁴

5.2. Menopause, oestrogens and tendon health: an unfavourable cocktail?

The menopausal transition overlaps the peak incidence of GTPS, which is no coincidence. 🌡️ Oestrogens are involved in regulating tendon collagen metabolism: their abrupt fall (and that of circulating androgens) alters the quality of the tendon matrix, increasing susceptibility to overload tendinopathies.⁵⁻⁶

  • Decreased type I collagen synthesis and increased altered cross-link maturation → a tendon less resilient to compressive loads.
  • Changes in fibre architecture : altered tenocyte turnover.
  • Low-grade systemic inflammation (oestrogen deprivation): heightened sensitivity to repeated microtrauma.
  • Changes in body composition : increased abdominopelvic fat mass, frequent weight gain, global muscle deconditioning.

⚖️ Cumulative sex-specific risk factors in women > 40 years

Strength of associations (estimated ORs or clinical consensus, Segal 2007, Allison 2016, Fearon 2013)

Sex-specific risk factors for GTPS reference (OR=1) 2× 3× 4× Female sex ×4 BMI ≥ 30 ×~3 Menopause / hypo-oestrogenism ×~2.5 Abductor weakness ×2 Associated low back pain ×2 Hip/knee osteoarthritis ×~1.7 Sedentary lifestyle + resumption of activity ×~1.5

ORs consolidated from Segal 2007 (n=3026), Fearon 2013, Allison 2016. For the menopause, indirect estimate based on the chronological incidence peak (40-60 years). OR estimates are indicative.

5.3. How do you stratify risk and adapt management?

🎯 It is useful to identify 3 main clinical subgroups of women > 40 years with GTPS, because the optimal therapeutic strategy differs:

SubgroupTypical profileTherapeutic priorityPrognosis
A. Sedentary postmenopausal woman + high BMIAged 55-65, BMI ≥ 28, global deconditioning, low back pain often associated, low activity levelGlobal approach: education + weight loss + physical reconditioning. Very gradual start (unloaded isometrics)Good if adherent; high risk of chronicity if a sedentary lifestyle persists
B. Active masters woman (recreational/sporting)Aged 45-60, runner or hiker, normal BMI, recent increase in training volumeTemporary load modification + progressive abductor strengthening. Return-to-running plan paced by tolerance (next-day pain included)Excellent (recovery in 12-16 wk.)
C. Woman with chronic “complicated GTPS”> 6 months of evolution, failed management, signs of central sensitisation (kinesiophobia, catastrophising), frequent psychological comorbiditiesReinforced biopsychosocial approach. Adjuncts discussed with the doctor: shockwave therapy, PRP (conflicting evidence). Work on central modulation (pain education, graded exposure)Variable; requires a multidisciplinary team
Stratifying clinically into subgroups (sedentary / masters / complicated chronic) avoids the pitfall of a single protocol. The masters woman benefits from a load-optimisation approach; the sedentary postmenopausal woman from complete reconditioning; the complicated chronic case from a multidisciplinary approach integrating psychosocial factors.

Additional practical implications in postmenopausal women :

  • 📋 Systematically screen for other tendinopathies : epicondylitis, rotator cuff tendinopathy, plantar fasciitis (more frequent after the menopause).
  • 🦴 Assess the bone status (DXA if indicated): a postmenopausal woman with progressive trochanteric pain must have a stress fracture or underlying bone fragility ruled out.
  • 💊 Discuss the advisability of a gynaecological opinion for women with menopausal symptoms (HRT, raloxifene, etc.), a shared decision outside the physiotherapist’s scope of practice.
  • 🥗 Metabolic approach : appropriate nutrition, sufficient protein, vitamin D, regular physical activity. BMI is one of the two major modifiable risk factors.
  • GTPS has a marked sex bias (F:M ≈ 4:1) explained by pelvic anatomy (wide pelvis, Q angle, femoral anteversion) and the menopausal transition (impact on tendon health).
  • Stratify into 3 subgroups : (A) sedentary postmenopausal + high BMI, (B) active masters, (C) complicated chronic. The therapeutic strategy differs for each.
  • Screen for associated tendinopathies (rotator cuff, epicondyle, plantar), for bone fragility and discuss gynaecological referral according to the overall menopausal picture.
  • BMI and a sedentary lifestyle are the major modifiable risk factors : managing them goes beyond the strict scope of physiotherapy and requires a multidisciplinary approach.
Bibliography - Chapter 5
  1. Fearon AM, Scarvell JM, Neeman T, Cook JL, Cormick W, Smith PN. Greater trochanteric pain syndrome: defining the clinical syndrome. Br J Sports Med. 2013;47(10):649-653. PMID 22983121.
  2. Birnbaum K, Siebert CH, Pandorf T, Schopphoff E, Prescher A, Niethard FU. Anatomical and biomechanical investigations of the iliotibial tract. Surg Radiol Anat. 2004;26(6):433-446. PMID 15378277.
  3. Grimaldi A, Mellor R, Hodges P, Bennell K, Wajswelner H, Vicenzino B. Gluteal Tendinopathy: A Review of Mechanisms, Assessment and Management. Sports Med. 2015;45(8):1107-1119. PMID 25969366.
  4. Allison K, Vicenzino B, Wrigley TV, Grimaldi A, Hodges PW, Bennell KL. Hip Abductor Muscle Weakness in Individuals with Gluteal Tendinopathy. Med Sci Sports Exerc. 2016;48(3):346-352. PMID 26418561.
  5. Hansen M, Kjaer M. Sex hormones and tendon. Adv Exp Med Biol. 2016;920:139-149. PMID 27535256.
  6. Magnusson SP, Hansen M, Langberg H, et al. The adaptability of tendon to loading differs in men and women. Int J Exp Pathol. 2007;88(4):237-240. PMID 17696904.
  7. Segal NA, Felson DT, Torner JC, et al. Greater trochanteric pain syndrome: epidemiology and associated factors. Arch Phys Med Rehabil. 2007;88(8):988-992. PMID 17678660.
  8. Speers CJ, Bhogal GS. Greater trochanteric pain syndrome. Br J Gen Pract. 2017;67(663):479-480. PMID 28963433.

6. What do concrete clinical cases teach us about GTPS? 📖

In this chapter: analysis of a classic case resolved by combining education + exercise (LEAP trial, Mellor 2018), diagnostic pitfalls (mimicked L5 radiculopathy, meralgia paraesthetica) documented by case reports indexed in PMC, and a complex case with an endoscopically operated tendon tear (Walker-Santiago 2020 review).

Studying the clinical cases published in the scientific literature offers a pragmatic perspective on GTPS. It helps recognise typical patterns, identify pitfalls and calibrate the intensity of investigation.

6.1. Analysis of a “classic” case: from assessment to resolution

The typical GTPS case corresponds to the average profile of the LEAP trial (Mellor 2018, BMJ):¹

  • Woman aged 50 to 65, BMI often > 27, lateral hip pain of insidious onset over several months.
  • Night pain when lying on the affected side, pain climbing stairs, pain on prolonged walking.
  • Failure of initial treatment (NSAIDs, relative rest, sometimes a previous injection that was transiently effective).
  • Physical examination: palpation reproducing the trochanteric pain, positive Single Leg Stance 30 s, positive FADER.

Recommended care pathway, based on LEAP:¹

  1. Initial assessment (1 session): history, clinical examination with the cluster, identification of modifiable risk factors, screening for red/yellow flags.
  2. Patient education (integrated into all sessions): deconstructing the “bursitis” myth, principles of decompression, management of positions.
  3. Supervised exercise programme over 8 weeks (14 sessions in LEAP): isometric → isotonic → functional phase.
  4. Daily home programme in parallel: 10-15 min/day.
  5. Reassessment at 6 and 12 weeks : load adjustment according to response, introduction of return to activity.
In the LEAP trial, the education + exercise protocol (14 physiotherapy sessions over 8 weeks) enabled 78.5 % of patients to achieve clinical success at 52 weeks, against 57.1 % for a corticosteroid injection and 51.7 % for simple observation. The advantage over injection appears from the 8th week and persists at one year for global improvement, but not for pain intensity.

6.2. The diagnostic challenge: when GTPS mimics another condition

GTPS is a great mimic. Several published clinical cases report atypical presentations in which the symptoms perfectly mimicked other conditions. ⚠️ Case 1: GTPS mimicking meralgia paraesthetica 🔬 A presentation with burning and paraesthesia over the anterolateral aspect of the thigh may initially point to compression of the lateral femoral cutaneous nerve (meralgia paraesthetica). When treatments targeting the nerve remain ineffective, meticulous clinical reassessment may reveal that palpation of the greater trochanter reproduces the familiar pain and that treatment focused on the gluteal tendinopathy resolves the symptoms. Implication: lateral thigh pain is not always neurogenic; systematically check trochanteric palpation.² Case 2: GTPS from a gluteus medius tear mimicking L5 radiculopathy 🔬 Weakness of hip abduction (positive Trendelenburg sign) associated with pain radiating along the lateral aspect of the lower limb is a classic picture of L5 radiculopathy. However, an inconclusive lumbar MRI should raise the possibility of a full-thickness tear of the gluteus medius tendon, which can produce a genuine Trendelenburg and misleading cutaneous radiating pain. Hip MRI is then the key to the diagnosis, and surgical repair can make the “pseudo-radicular” symptoms disappear.³

🚩 Common diagnostic pitfalls in GTPS

  • Positive Trendelenburg + lateral pain extending below the knee → do not settle for a radicular diagnosis before having ruled out a gluteus medius tendon tear (hip MRI)
  • Anterolateral thigh paraesthesia resistant to meralgia treatment → systematically palpate the greater trochanter
  • GTPS in a young, sporty man with no obvious risk factor → look for stress fracture, FAI, piriformis muscle syndrome, iliopectineal impingement
  • Sudden unilateral pain after a fall in an older person → fracture of the greater trochanter or femoral neck above all
  • Progressive symmetrical bilateral GTPS in a young adult → suspected axial spondyloarthropathy, rheumatoid arthritis or fibromyalgia as comorbidity

6.3. Study of a complex case: the operated tendon tear

Some patients do not respond to well-conducted conservative management over > 6 months. In these cases, it is necessary to investigate further and to consider 2nd/3rd line options. 🔧 Typical profile :

  • Woman ≥ 55-65 years with chronic GTPS, conservative failure ≥ 6 months;
  • Marked and persistent abductor weakness (positive Trendelenburg) despite rehabilitation;
  • MRI showing a high-grade partial or full-thickness tear of the gluteus medius tendon.

Treatment options in case of failure :

  1. Focused shockwave therapy : if symptoms predominate but without a complete tear. The Harding 2024 systematic review with meta-analysis (Musculoskeletal Care, 12 studies, n = 1,121) finds no statistically significant difference in pain or function against control; it retains shockwave therapy as a defensible option only in view of its low rate of adverse effects.⁴ Another 2024 meta-analysis (Rhim, 8 trials, 754 patients, 7 at high risk of bias) finds lower pain at 2-4 months against other treatments, a functional gain at 6 months below the threshold of clinical relevance and an advantage of focused over radial shockwaves.¹¹
  2. PRP : better than corticosteroid injection at 12 and 24 weeks (Fitzpatrick 2019, AJSM, n = 80; 2-year follow-up as an open-label extension),⁵ but with no difference against placebo in two trials (Thompson 2019; Atchia 2025):¹⁰,⁹ a medical option whose own efficacy is not established.
  3. Endoscopic tendon repair surgery (Walker-Santiago 2020, systematic review): re-attachment of the gluteus medius/minimus under arthroscopy. Progressive restoration of strength, resolution of pain in the majority of cases at 1-2 years post-op, but requires rigorous post-op rehabilitation (8-12 months).⁶
  4. Special cases after THR : persistent trochanteric pain after hip arthroplasty → look for a local mechanism (implant impingement, intra-articular fragment, low-grade infection), do not settle for a diagnosis of “secondary GTPS”.
  • The typical LEAP case (woman aged 50-65, high BMI, insidious pain) responds well to an education + exercise protocol over 8-12 weeks: 77 % success at 1 year.
  • Pitfalls : meralgia paraesthetica, L5 radiculopathy, stress fracture, piriformis syndrome, FAI. Familiar trochanteric palpation remains the diagnostic pivot.
  • In case of failure ≥ 6 months : hip MRI to rule out a tear, then shockwave therapy, PRP or endoscopic surgery, to be discussed with the doctor: their evidence is conflicting and the surgical indication remains individual.
  • Always look for a secondary mechanical cause in persistent post-arthroplasty or post-traumatic GTPS.
Bibliography - Chapter 6
  1. Mellor R, Bennell K, Grimaldi A, et al. LEAP trial. BMJ. 2018;361:k1662. PMID 29720374.
  2. Grimaldi A, Mellor R, Hodges P, Bennell K, Wajswelner H, Vicenzino B. Gluteal Tendinopathy: A Review of Mechanisms, Assessment and Management. Sports Med. 2015;45(8):1107-1119. PMID 25969366.
  3. Lequesne M, Mathieu P, Vuillemin-Bodaghi V, Bard H, Djian P. Gluteal tendinopathy in refractory greater trochanter pain syndrome: diagnostic value of two clinical tests. Arthritis Rheum. 2008;59(2):241-246. PMID 18240186.
  4. Harding D, Cameron L, Monga A, Winter S. Is shockwave therapy effective in the management of greater trochanteric pain syndrome? A systematic review and meta-analysis. Musculoskeletal Care. 2024;22(2):e1892. doi:10.1002/msc.1892. PMID 38777616.
  5. Fitzpatrick J, Bulsara MK, O'Donnell J, Zheng MH. Leucocyte-Rich PRP Treatment of Gluteus Medius and Minimus Tendinopathy: A Double-Blind RCT With 2-Year Follow-up. Am J Sports Med. 2019;47(5):1130-1137. PMID 30840831.
  6. Walker-Santiago R, Wojnowski NM, Lall AC, et al. Platelet-Rich Plasma Versus Surgery for the Management of Recalcitrant Greater Trochanteric Pain Syndrome: A Systematic Review. Arthroscopy. 2020;36(3):875-888. PMID 31882270.
  7. Speers CJ, Bhogal GS. Greater trochanteric pain syndrome: a review of diagnosis and management in general practice. Br J Gen Pract. 2017;67(663):479-480. PMID 28963433.
  8. Long SS, Surrey DE, Nazarian LN. Sonography of greater trochanteric pain syndrome and the rarity of primary bursitis. AJR Am J Roentgenol. 2013;201(5):1083-1086. AJR.
  9. Atchia I, Ali M, Oderuth E, Holleyman R, Malviya A. Efficacy of Platelet-Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome: A Double-Blinded Randomized Controlled Trial. J Bone Joint Surg Am. 2025;107(5):444-451. PMID 39804899.
  10. Thompson G, Pearson JF. No attributable effects of PRP on greater trochanteric pain syndrome. N Z Med J. 2019;132(1507):22-32. PMID 31830014.
  11. Rhim HC, Shin J, Beling A, et al. Extracorporeal Shockwave Therapy for Greater Trochanteric Pain Syndrome: A Systematic Review with Meta-Analysis of Randomized Clinical Trials. JBJS Rev. 2024;12(8). PMID 39297780.

7. How do you apply these recommendations concretely in your practice?

In this chapter: red flags and medical referral (Finucane 2020), yellow flags and psychological collaboration, outcome measurement (provisional ICON measurement set, VISA-G), overcoming barriers to evidence-based implementation and the place of shared patient-clinician decision-making.

Applying evidence-based recommendations is the bridge between scientific knowledge and tangible improvement in patient outcomes. It requires not only understanding the data but also a pragmatic strategy of referral, measurement and continuous improvement. 🧑‍⚕️

7.1. When, and to which other healthcare professionals, should you refer?

The fundamental competence of the modern physiotherapist includes recognising the limits of their scope of practice. Identifying red flags (Finucane 2020) is a non-negotiable prerequisite.¹ Criteria for medical referral 🚨 :

  • Red flags (see chapter 1): recent history of cancer, severe non-mechanical night pain, fever, unexplained weight loss, progressive neurological deficit, high-energy trauma, suspected stress fracture.
  • Failure of well-conducted conservative treatment ≥ 8-12 weeks → consult a doctor to discuss shockwave therapy / PRP / imaging / injection.
  • Suspected complete tendon tear (major Trendelenburg, marked abductor weakness) → hip MRI + orthopaedic opinion.
  • Significant psychiatric comorbidities (major depression, disabling anxiety disorders) → psychological referral or general practitioner.
  • Suspected systemic disease (spondyloarthropathy, rheumatoid arthritis, fibromyalgia) → rheumatologist.
  • Progressive symmetrical bilateral GTPS → full rheumatological work-up.

Interprofessional collaboration 🤝 :

  • General practitioner : for short-course NSAID prescription if needed, requests for investigations, specialist referral.
  • Sports physician / physical and rehabilitation medicine physician : for recreational/competitive athletes, shockwave therapy, PRP.
  • Rheumatologist : suspected inflammatory condition, rheumatological comorbidities.
  • Orthopaedic surgeon : suspected tendon tear, prolonged conservative failure.
  • Dietitian / nutritionist : high BMI (one of the major modifiable risk factors).
  • Clinical psychologist / pain specialist : kinesiophobia, catastrophising, anxiety-depressive comorbidities, signs of central sensitisation.

7.2. How do you measure outcomes and overcome barriers to implementation?

📊 The PROMs (Patient-Reported Outcome Measures) are standardised questionnaires that quantify progress from the patient’s point of view. For GTPS, the most relevant are:

  • ICON provisional measurement set (2024) : global rating of change, night pain, time to onset of pain in single-leg stance, pain on stairs, pain self-efficacy, abductor strength. The consensus found that no available measure has sufficient clinimetric properties for a definitive set; this provisional set should guide the choice of measures in clinical practice as well as in research.⁹
  • VISA-G (Victorian Institute of Sport Assessment - Gluteal): 8 items, developed and validated for gluteal tendinopathy;² ICON also judges it to have insufficient clinimetrics, and retains it, with the EQ-5D-5L and pain over the past week, for clinical trials.⁹
  • HOOS (Hip disability and Osteoarthritis Outcome Score): generic hip measure, 5 subscales (pain, symptoms, ADL, sport, quality of life); it is not among the measures retained by ICON.
  • Numerical Pain Rating Scale (NPRS) 0-10 : simple, validated.
  • GROC (Global Rating of Change): perceived self-assessment of change (-7 to +7), used in LEAP.
  • FABQ (Fear-Avoidance Beliefs Questionnaire): screening for kinesiophobia.

🛠️ Overcoming barriers to the implementation of EBP

Summary of the barriers most cited by physiotherapists and levers for improvement

EBP barriers and levers in physiotherapy 🚧 BARRIERS (most cited in private practice) 🚀 LEVERS (validated strategies) Lack of time for consultation and critical reading of the literature Validated syntheses (CPG, JOSPT) + digital PROM tools + standardised routines Lack of skills in research / critical appraisal Continuing education, journal clubs online community of practice Limited access to databases / paywalled articles Open access resources PubMed PMC + organisational advocacy Patient inertia and habits (“I prefer my massage”) Shared decision-making (SDM) + evidence-based patient education

Synthesis of several reviews on barriers to EBP in physiotherapy. Shared decision-making (SDM) is a powerful lever to align patient expectations with scientific data.

Shared decision-making (SDM) 🤝: a collaborative process in which clinician and patient choose the treatment strategy together. For GTPS, a concrete example:

  • Present the 3 evidence-based options to the patient: (1) education + exercise (1st line, long-term success but requires commitment), (2) corticosteroid injection (fast but transient), (3) waiting alone (an option for a mildly disabling acute episode).
  • Explain the real figures (LEAP 2018) using understandable language.
  • Identify the values and preferences of the patient (do they prefer immediate relief or a lasting solution? Which activities do they want to return to?).
  • Jointly build the treatment plan, with concrete goals and reassessment criteria.
  • Referral is crucial: red flags → doctor/emergency department, yellow flags → psychologist, conservative failure ≥ 6-8 wk. → doctor for escalation.
  • The interprofessional collaboration (doctor, rheumatologist, surgeon, dietitian, psychologist) is essential for complex cases.
  • Measure outcomes with the provisional ICON measurement set (global rating of change, night pain, pain in single-leg stance and on stairs, self-efficacy, abductor strength), supplemented where needed by the VISA-G.
  • The barriers to EBP (time, skills, resources) are real but can be overcome through continuing education, digital tools and shared decision-making.
Bibliography - Chapter 7
  1. Finucane LM, Downie A, Mercer C, et al. International Framework for Red Flags for Potential Serious Spinal Pathologies. J Orthop Sports Phys Ther. 2020;50(7):350-372. PMID 32438853. doi:10.2519/jospt.2020.9971.
  2. Fearon AM, Ganderton C, Scarvell JM, et al. Development and validation of a VISA tendinopathy questionnaire for greater trochanteric pain syndrome, the VISA-G. Man Ther. 2015;20(6):805-813. PMID 25870117.
  3. Mellor R, Bennell K, Grimaldi A, et al. LEAP trial. BMJ. 2018;361:k1662. PMID 29720374.
  4. Bremer T, Nicklen P, Fearon A, Morrissey D. The efficacy of gluteal tendinopathy treatments: A systematic review. Clin Rehabil. 2025. doi:10.1177/02692155251327298.
  5. Plinsinga ML, Coombes BK, Mellor R, Vicenzino B. Individuals with Persistent GTPS Exhibit Impaired Pain Modulation. Pain Med. 2020;21(11):2964-2974. PMID 32232468.
  6. Grimaldi A, Mellor R, Hodges P, Bennell K, Wajswelner H, Vicenzino B. Gluteal Tendinopathy: A Review of Mechanisms, Assessment and Management. Sports Med. 2015;45(8):1107-1119. PMID 25969366.
  7. Speers CJ, Bhogal GS. Greater trochanteric pain syndrome. Br J Gen Pract. 2017;67(663):479-480. PMID 28963433.
  8. Hoffmann TC, Légaré F, Simmons MB, et al. Shared decision making: what do clinicians need to know and why should they bother? Med J Aust. 2014;201(1):35-39. PMID 24999896.
  9. Fearon AM, Grimaldi A, Mellor R, et al. ICON 2020-International Scientific Tendinopathy Symposium Consensus: the development of a core outcome set for gluteal tendinopathy. Br J Sports Med. 2024;58(5):245-254. PMID 38216320.

And after this reading?

This article is part of a collection of evidence-based clinical syntheses. A question, feedback, a correction to suggest? Contact us directly through the WhatsApp button at the bottom right of the screen.

💪Learn moreGreater trochanteric pain syndrome: exercises and self-rehabilitation →

Behind this article

An author who explains, a reviewer who checks.

How we write and check our content

Anthony Baillon, physiotherapist and co-founder of Physio Learning
✍️ Author

Anthony Baillon

Physiotherapist · co-founder of Physio Learning

Marked for life by his first four-hour lecture without a single image, he took a master’s in instructional design so that it would never happen to anyone again. He hunts down publication bias and unreadable slides with the same intransigence.

PhysiotherapistInstructional designerCare design
Follow on LinkedIn
Robin Vervaeke, head of scientific content at Physio Learning✓ Verified

Robin Vervaeke

Scientific lead

Physiotherapist specialising in neuro-musculoskeletal practice and holder of a master’s in public health. He checks the methodological rigour of every article: primary sources, levels of evidence, no exceptions.

Neuro-musculoskeletalM2 Public health
Follow on LinkedIn

Share